RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.

Clinical trial NCT05127798 · UNKNOWN

Trial details

NCT number: NCT05127798
Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda
Status: UNKNOWN
Study type: OBSERVATIONAL

Acute Myeloid Leukemia, Adult

Start date: 2021-03-01
Primary completion: 2024-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.